Inventor · disambiguated record
Martyn Kim Robinson
Also filed as: ROBINSON MARTYN · ROBINSON MARTYN K · ROBINSON MARTYN KIM
16 granted patents·9 pending applications·402 citations·filing 1990–2024
94Inventor score
Top patents by PatentIndex Score
25 records- 0197US7872106B2Sclerostin-binding antibodiesAMGEN INC·Filed 2008·Granted Jan 18, 2011·86 cites·25 claims
- 0296US7592429B2Sclerostin-binding antibodyUCB SA·Filed 2006·Granted Sep 22, 2009·166 cites·5 claims
- 0395US8784823B2Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind CD154 and uses thereofUCB PHARMA SA·Filed 2012·Granted Jul 22, 2014·38 cites·7 claims
- 0495US8293237B2Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind CD154 and uses thereofBURKLY LINDA C·Filed 2008·Granted Oct 23, 2012·40 cites·19 claims
- 0587US8003108B2Sclerostin epitopesAMGEN INC·Filed 2006·Granted Aug 23, 2011·11 cites·15 claims
- 0684US2024269274A1Treatment for bone diseasesUCB PHARMA SA·Filed 2024·Application pending·0 cites
- 0780US2023135399A1Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind cd154 and uses thereofUCB Biopharma SRL·Filed 2022·Application pending·0 cites
- 0879US9321840B2Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind CD154 and uses thereofUCB PHARMA SA·Filed 2014·Granted Apr 26, 2016·2 cites·15 claims
- 0979US6407214B1Antibodies against E-selectinCELLTECH THERAPEUTICS LTD·Filed 2000·Granted Jun 18, 2002·11 cites·9 claims
- 1078US7931900B2Method for the treatment of multiple sclerosis by inhibiting IL-17 activityUCB PHARMA SA·Filed 2008·Granted Apr 26, 2011·5 cites·4 claims
- 1177US6204007B1Antibodies against E-selectinCELLTECH THERAPEUTICS LTD·Filed 1995·Granted Mar 20, 2001·25 cites·13 claims
- 1272US11896667B2Treatment for bone diseasesUCB PHARMA SA·Filed 2020·Granted Feb 13, 2024·0 cites·19 claims
- 1371US5120654ACloning and use of the transaminase gene ilveHOECHST AG·Filed 1990·Granted Jun 9, 1992·13 cites·2 claims
- 1470US7662609B2E.coli host cells with modified PhoS/PstS periplasmic phosphate-binding proteins, and method of manufacturing recombinant fabsUCB PHARMA SA·Filed 2003·Granted Feb 16, 2010·1 cites·7 claims
- 1570US2024400664A1Anti-Sclerostin Antibodies and Their Use to Treat Bone Disorders as Part of a RegimenAMGEN INC·Filed 2023·Application pending·0 cites
- 1668US10799583B2Treatment for bone diseasesUCB PHARMA SA·Filed 2018·Granted Oct 13, 2020·0 cites·34 claims
- 1766US2019233530A1Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind cd154 and uses thereofUCB BIOPHARMA SPRL·Filed 2019·Application pending·0 cites
- 1863US2015351417A1Edible materials and their manufactureINTERCONTINENTAL GREAT BRANDS LLC·Filed 2013·Application pending·0 cites
- 1961US9925260B2Treatment for bone diseasesUCB PHARMA SA·Filed 2013·Granted Mar 27, 2018·0 cites·39 claims
- 2061US2010285530A1E.Coli Host Cells with Modified Phos/Psts Periplasmic Phosphate-binding Proteins, and Method of Manufacturing Recombinant FabsUCB PHARMA SA·Filed 2009·Application pending·0 cites
- 2158US2016200823A1Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind cd154 and uses thereofUCB PHARMA SA·Filed 2016·Application pending·0 cites
- 2251US2010036091A1Antibody-based diagnostics and therapeuticsAMGEN INC·Filed 2007·Application pending·0 cites
- 2349US5091314ACloning and use of transaminase gene tyrbHOECHST AG·Filed 1990·Granted Feb 25, 1992·4 cites·2 claims
- 2448US11851483B2Anti-sclerostin antibodies and their use to treat bone disorders as part of a regimenAMGEN INC·Filed 2015·Granted Dec 26, 2023·0 cites·13 claims
- 2548US2007269428A1Method for the Treatment of Multiple Sclerosis by Inhibiting Il-17 ActivityCELLTECH R&D LTD·Filed 2004·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Martyn Kim Robinson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →